Individual risk assessment for intracranial haemorrhage during thrombolytic therapy

This publication has 29 references indexed in Scilit:

• The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment
  New England Journal of Medicine, 1992
• Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator
  The American Journal of Medicine, 1992
• Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors
  Journal of the American College of Cardiology, 1992
• Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
  Circulation, 1991
• Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands
  Journal of the American College of Cardiology, 1989
• Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction
  The American Journal of Medicine, 1988
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1988
• Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands.
  Heart, 1988
• Update from the thrombolysis in myocardial infarction trial
  Journal of the American College of Cardiology, 1987
• Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?
  Circulation, 1986